CBS and colonic neoplasm: Benserazide (26) inhibited colon cancer cell proliferation in HCT116 and HT29 cell lines, both highly expressing CBS, impaired cellular bioenergetics in HCT116 cells and suppressed colon cancer tumor growth in mice [125].